Bio-Techne and MedSanTek Team Up to Boost Research in Turkey and Azerbaijan
Bio-Techne and MedSanTek Team Up to Boost Research in Turkey and Azerbaijan
Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities today announced a partnership with MedSanTek. Under the agreement, MedSanTek becomes the distributor of Bio-Techne's R&D Systems, Novus, Tocris, Protein Simple, Advanced Cell Diagnostics (ACD), and Asuragen brands across Turkey.
Bio-Techne公司（纳斯达克：TECH）是一家全球生命科学公司，为研究和临床诊断界提供创新工具和生物活性试剂，今天宣布与MedSanTek达成合作伙伴关系。根据协议，MedSanTek成为Bio-Techne的R&D系统、Novus、Tocris、Protein Simple、爱文思控股电芯诊断（ACD）和Asuragen品牌在土耳其的分销商。
Founded in the late 2000s, MedSanTek is a leading in vitro diagnostics and research products distributor, serving Turkey and Azerbaijan. Partnering with global brands, the company provides high-quality solutions in molecular biology, immunology, cancer research, cell therapy, and more, earning a reputation for innovation and customer satisfaction in advancing science and healthcare.
MedSanTek成立于2000年代末，是一家领先的体外诊断和研究产品分销商，服务于土耳其和阿塞拜疆。该公司与全球品牌合作，提供分子生物学、免疫学、抗癌医药、细胞治疗等领域的高质量解决方案，因在推进科学和医疗保健方面的创新和客户满意度而享有声誉。
